Targeted Strategies for Today's Evolving Markets

MissionIR Blog

MissionIRNewsBreaks – VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQB: ABCCF) Announces Appointment of Chief Customer Officer

VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQB: ABCCF) this morning announced its appointment of Joel Mallard as its new chief customer officer (CCO). Per the update, Mallard will assume the position effective August 20, 2018, and will be tasked with building and leading VIVO’s sales teams and strategy across all markets moving forward. Mallard brings more than 20 years of sales, marketing and innovation experience to the VIVO team, having previously held senior roles at Diageo and News Corp. Notably, he also boasts over 13 years of experience in leadership roles in the alcoholic beverage industry. “Joel is a welcome addition to the VIVO team. His extensive expertise in sales, marketing and product innovation and in the beverage alcohol category are highly valued,” Barry Fishman, CEO of VIVO, stated in the news release. “His leadership role will include developing a comprehensive understanding of our customers and creating strategies to maximize customer acquisition, retention and profitability. We are thrilled to have Joel as the chief customer ambassador for our brands including Beacon Medical, Fireside Cannabis and Lumina Wellness.”

To view the full press release, visit http://ibn.fm/bsDuj

About VIVO Cannabis™

VIVO is recognized for trusted, high-quality products and services. It holds production and sales licences from Health Canada, and its world-class indoor cultivation facility in Napanee, Ontario contains proprietary plant-growing technology. VIVO is expanding its production capacity and pursuing partnership and product development opportunities domestically, as well as in select international markets, including Germany, Australia and Israel. VIVO recently announced that it has entered into a definitive agreement to acquire 100% of the issued and outstanding share capital of Canna Farms Limited, a premium cannabis company based in Hope, British Columbia. For more information, visit the company’s website at www.VIVOCannabis.com

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in MissionIRNewsBreaks, VIVO Cannabis Inc. ABCCF | Leave a comment

MissionIRNewsBreaks – Sunniva Inc. (CSE: SNN) (OTCQX: SNNVF) to Provide Ultra-Purified Cannabis Extracts Through White Label Agreement

Sunniva (CSE: SNN) (OTCQX: SNNVF) has penned a white label services agreement to provide Cannabis Strategic Ventures, Inc. (OTC: NUGS) with top-quality cannabis extracts for its Pure Organix™ brand. In discussing the venture, Sunniva CEO Tony Holler stated, “As one of the highest quality producers in the marketplace, we believe we are in an excellent position to provide brand product manufacturing services for Cannabis Strategic. Both of our firms share the vision of becoming leaders in providing clean, medical grade cannabis products to consumers.”

To view the full article, visit http://ibn.fm/Loayv

About Cannabis Strategic Ventures, Inc.

Cannabis Strategic Ventures is based in Los Angeles and is focused on supporting entrepreneurial growth within the fast-growing legal cannabis sector. The company recently completed a name and symbol change from Cascade Energy, Inc. Cannabis Strategic Ventures offers outsourced personnel solutions that are tailor-made to match the growth dynamics of cannabis cultivators, manufacturers, dispensaries, and other cannabis marketplace participants. Cannabis Strategic Ventures is publicly traded on the OTC Markets with the stock symbol NUGS. For more information, visit the company’s website at www.CannabisStrategic.com

About Sunniva Inc.

Sunniva, through its subsidiaries, is a vertically integrated cannabis company operating in the world’s two largest cannabis markets – Canada and California – where it is committed to delivering safe, high-quality products and services at scale and creating trusted Sunniva branded cannabis products. The company’s vision is to become one of the lowest cost, highest quality vertically integrated cannabis producers in the markets it serves by building large scale purpose-built current cGMP designed greenhouses and expansion of retail locations, offering better quality assurance with cannabis products free from pesticides, providing better customer access to cannabis education and sourcing better therapeutic delivery devices. Sunniva’s management and board of directors have a proven track record for creating significant shareholder value both in the healthcare and biotech industries. For more information, visit the company’s website at www.Sunniva.com

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in MissionIRNewsBreaks, Sunniva Inc. SNNVF | Leave a comment

Cannabis Strategic Ventures, Inc. (NUGS) Prepares to Uplist with Renewed Focus on Financial Reporting

  • Cannabis Strategic Ventures working toward fully reporting status with SEC, OTC exchange
  • Company’s portfolio includes professional staffing services, high-quality cannabis oils
  • Cannabis industry expected to be responsible for more than 600,000 jobs by 2025

Cannabis Strategic Ventures, Inc. (OTC: NUGS) has pursued its mission to foster legalized cannabis industry value-adds by building a portfolio of vertically integrated companies, and now the company is preparing to uplist on the public markets by refocusing its efforts on bringing its financial reporting up to par.

“While building on our business portfolio is very important to us, bringing the Company up to fully reporting status and up listing to a higher OTC Markets tier is also a top priority,” Cannabis Strategic Ventures CEO Simon Yu stated in a recent news release (http://ibn.fm/fcMYL). “We believe it is important to provide the reliable and transparent information to our shareholders.”

The company announced on July 26 that it had finished the financial audits for fiscal years 2016 and 2017 and is now in the process of filing full financial reports and completing its audit for the fiscal year ended March 31.

As Cannabis Strategic Ventures achieves fully reporting status with the Security and Exchange Commission (SEC), it also hopes to gain greater recognition and a stronger investment base on the higher-tier exchange, which could be beneficial to current stock holders.

The company’s mission is to build a profitable enterprise in the $10 billion cannabis and $900 million hemp industries by building brands that support all facets of business operations in those markets. Within the next seven years, employment in the cannabis industry across the United States is expected to triple from 200,000 people to 630,000, according to New Frontier Data research cited by The Desert Sun (http://ibn.fm/GXYfG). The ancillary industry effect is expected to be much more widespread. In 2017, California — the leading marijuana employer state — reported 38,233 jobs directly tied to the cannabis industry and 18,165 jobs in “related” avenues, according to Arcview Market Research. Over the next three years, the cannabis industry is expected to create nearly one job for every 1,000 people in the country.

That’s encouraging news for Cannabis Strategic Ventures as it works to build on the non-cannabis employment and staffing services provided by the company’s subsidiary, Worldwide Staffing Group, Inc., in order to expand its business operations further into the cannabis staffing arena with an emphasis on the California markets. NUGS’ BudHire subsidiary provides outsourced employment service crafted to meet the needs of cannabis-related businesses by matching qualified candidates to temporary, seasonal and permanent cannabis production staffing opportunities. It also provides human resources consulting and other professional employment services to the cannabis industry.

Pure Applied Sciences Inc., another of the company’s subsidiaries, produces high-quality cannabis oils that conform with good manufacturing practices protocols (cGMP) and the guidelines for active pharmaceutical ingredients (API) in the United States. The oils are marketed under its PureOrganix brand.

For more information, visit the company’s website at www.CannabisStrategic.com

About MissionIR

MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

For more information, visit www.MissionIR.com

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in Cannabis Strategic Ventures Inc. NUGS | Leave a comment

ChineseInvestors.com, Inc.’s (CIIX) CBD Division Holds Promise, as Detailed in MoneyTV Interview

  • CBD division offers potential for shareholders, as shared on MoneyTV
  • Over 70 retail establishments offering ChineseHempOil.com products in Los Angeles
  • Ground work for wholly owned subsidiary focused on CBD products began in 2016
  • Continued commitment to cryptocurrency education for the Chinese-speaking community worldwide

ChineseInvestors.com, Inc. (OTCQB: CIIX), a company focused on providing financial information and services to the Chinese-speaking community worldwide, will soon spin off its cannabis-related products into the wholly owned subsidiary ChineseHempOil.com, Inc. The spinoff was originally scheduled for May 31, 2018, but was temporarily postponed as CIIX continues to develop domestic sales channels.

CEO Warren Wang joined Donald Baillargeon on MoneyTV to discuss CIIX’s CBD division and share new developments and the potential that this investment has for shareholders (http://ibn.fm/U1SXy). This new subsidiary has two offices, one in China focused on cosmetics and CBD infusion and the other in Los Angeles, California, selling CBD oil for Chinese consumers. In the interview, Wang highlighted CIIX’s three divisions as being centered on hemp oil, Chinese investors and cryptocurrency. The focus of the conversation was on the unique opportunity in which the hemp oil division is positioned. Wang stated, “My idea is to spin off the hemp oil division hopefully by end of the year.” The full interview can be found at www.MoneyTV.net.

Though Wang describes CBD products and education as personal passions, the company is too diversified to focus all of his attention in that direction. CIIX is the first company to educate the Chinese consumer on the benefits of CBD, starting first in the U.S. and then expanding. Whether the conversation is around CBD, cryptocurrency or investing, CIIX remains dedicated to providing the best education available to Chinese-speaking investors.

Earlier this year, CIIX appointed Nina Wang as vice president of sales for U.S. consumer retail/e-commerce. Through her efforts, ChineseHempOil.com has developed strategic relationships with over 70 retail establishments in the Los Angeles area. Plans are in place to expand product placement into Northern California, furthering the process to complete the spin-off of all hemp-related assets (http://ibn.fm/qpAWQ). Wang stated in his interview with MoneyTV that the goal for the next year, in addition to the successful spin-off, is to increase brand awareness.

The company first started laying the groundwork to capitalize on the growing demand for cannabidiol-based nutrition and health products in 2016. In 2017, ChineseCBDoil.com was launched, offering the first online CBD health product store in the Chinese language. Soon after, a ‘Yelp’ style social media application available in the Apple App Store was launched as a database of marijuana dispensaries and cannabis strains to provide consumers with a database of reviews and locations. The planned spinoff of such assets will allow CIIX to focus on its new cryptocurrency division and its core financial education division while simultaneously allowing ChineseHempOil.com to expand within the rapidly growing cannabis industry.

CIIX is committed to cryptocurrency education for the Chinese-speaking community. The company provides education opportunities by broadcasting daily videos from the NYSE titled ‘Bitcoin MultiMillionaire,’ broadcasting the television program ‘Bitcoin Talk Show’ with a reach of over 500,000 Chinese people in North America, redistributing Chinese translations of The Bad Crypto Podcast and offering cryptocurrency trading courses online in both English and Chinese through its newly established Bitcoin Trading Academy LLC. These are just some of the strategic ways in which CIIX has set itself apart as the leading financial information website for Chinese-speaking investors globally.

For more information, visit the company’s website at www.ChineseInvestors.com

About MissionIR

MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

For more information, visit www.MissionIR.com

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in Chineseinvestors.com, Inc. CIIX | Leave a comment

MissionIRNewsBreaks – Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) Aims to Address Customers’ Needs through QuadSight Prototype Sales

Foresight Autonomous Holdings (NASDAQ: FRSX) (TASE: FRSX) is committed to leading the way in providing inimitable automotive vision systems solutions and growing its foothold in the industry while addressing customers’ needs. An article discussing the company’s recent achievements reads: “In addition, Foresight announced a prototype sale of its breakthrough QuadSight quad-camera vision system designed for use in the autonomous and semi-autonomous vehicle market. A leading Chinese manufacturer of electric and autonomous vehicles ordered the prototype in order to evaluate the system’s performance with its current electric vehicles. Depending on the test results, the overseas manufacturer could implement QuadSight into future electric autonomous vehicle designs, a move that could mean significant revenue generation for Foresight.”

To view the full article, visit http://ibn.fm/lUIfp

About Foresight

Foresight Autonomous Holdings Ltd., founded in 2015, is a technology company engaged in the design, development and commercialization of stereo/quad-camera vision systems and V2X cellular-based solutions for the automotive industry. Foresight’s vision systems are based on 3D video analysis, advanced algorithms for image processing and sensor fusion. The company, through its wholly owned subsidiary Foresight Automotive Ltd., develops advanced systems for accident prevention which are designed to provide real-time information about the vehicle’s surroundings while in motion. The systems are designed to improve driving safety by enabling highly accurate and reliable threat detection while ensuring the lowest rates of false alerts. The company’s systems are targeting the Advanced Driver Assistance Systems (ADAS), semi-autonomous and autonomous vehicle markets. The company estimates that its systems will revolutionize automotive safety by providing an automotive-grade, cost-effective platform and advanced technology. For more information, visit the company’s website at www.ForesightAuto.com

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in Foresight Autonomous Holdings Ltd. FRSX, MissionIRNewsBreaks | Leave a comment

Pressure BioSciences, Inc. (PBIO) Receives Major Zacks Valuation Update

  • Zacks Small-Cap Research Report ups fair market value of PBIO stock by $2 per share
  • Collaborative development project focused on liquid food preservation without chemical additives, extended shelf-life at room temperature and greater safety based upon PBIO’s patented Ultra Shear Technology (“UST”), as announced by Ohio State University and PBIO
  • Unique UST pressure processing technology platform can be applied across many lucrative industries in addition to food, including pharmaceutical, nutraceutical, industrial lubricants, paint and cosmetic sectors
  • Non-thermal processing market estimated at $818.6 million in 2017, projected to reach $1.22 billion by 2022 at a CAGR of 8.4 percent from 2017
  • Widening applicability of high pressure processing equipment and government grants toward development of shelf-stable food technologies a major factor in growth of food and beverage processing industry

Pressure BioSciences Inc. (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based technology and products in the worldwide life sciences industry, is forecast to grow at a compound annual growth rate (CAGR) of 76 percent in the next five fiscal years from 2018 to 2022, according to a Zacks Research Report issued on July 26, 2018 (http://ibn.fm/DuQR3). In the Zacks Small-Cap Research Report, the company’s fair value for PBIO shares is raised to $12/share from a previous $10/share. Zacks’ optimism regarding Pressure BioSciences is tied to a number of recent achievements and collaborative research programs, expansion of the company’s sales and marketing capabilities and a newly established multinational co-marketing partner, ISS Inc.

Pressure BioSciences is a Massachusetts-based company that manufactures high-pressure-based equipment and laboratory instrumentation for the life sciences industry. Its patented Ultra Sheer Technology (“UST”) offers the potential to produce highly stable, clean and cost-effective nanoemulsions that facilitate the production of food products with enhanced shelf lives and without the need for chemicals or preservatives, as the company noted in a recent article (http://ibn.fm/Pcr8i). The company believes that its UST technology platform can be applied across a multitude of industries seeking to satisfy consumer demand for chemical- and preservative-free food products that have longer shelf-life, greater safety and do not require refrigeration until opened.

As the Zacks report points out, PBIO and its patented high pressure, ultra-shear technology could potentially be used by liquid food and beverage makers to offer healthier drinks and juices by reducing heat exposure in the preservation process. Introducing a combined application of elevated pressure, intense shear forces and controlled times and temperatures – without exposing liquid foods and beverages to taste-destroying levels of heat – means that foods such as milk, other dairy products and juices could be packaged and preserved for transportation and longer-term storage without the need for refrigeration.

Researchers at Ohio State University, along with their PBIO collaborators, recently announced the U.S. Department of Agriculture’s National Institute of Food and Agriculture has awarded a four-year, $891,000 grant to the university to develop a new manufacturing technology to preserve liquid food and beverages based on PBIO’s ultra-shear technology (http://ibn.fm/4fSV6). Ohio State has granted PBIO a $318,000 sub-contract to build a working benchtop instrument and a pilot plant floor model UST machine. PBIO has already begun work on this project.

The primary goal of the program is to develop and make available for commercialization a continuous-flow manufacturing technology that will prepare liquid foods and beverages with a preservation process that not only retains nutritional qualities but delivers room temperature shelf stability without requiring refrigeration or chemical additives. UST offers the potential to satisfy this long sought-after demand by food processors while meeting consumer expectations for tasty, safe and shelf-stable liquid foods and beverages, as PBIO stated in a July 19 news release (http://ibn.fm/gnzxT).

“The ultimate goal of this collaborative project is for consumers to benefit from the increased availability of wholesome, healthy, better-tasting, shelf-stable, clean label liquid food and beverage options,” Richard T. Schumacher, president and CEO of PBIO, said in the news release. “Imagine liquid foods like milk shipped and stored at room temperature for extended periods of time post-processing, while retaining superior nutritional and taste qualities. The advantages and cost-savings to the consumer and dairy industry could be game-changing. The advantages and cost savings to schools, the military, disaster relief agencies, and other such groups could be equally significant. This technology development is very exciting, and potentially very rewarding, for all stakeholders in PBI.”

For more information, visit the company’s website at www.PressureBioSciences.com

About MissionIR

MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

For more information, visit www.MissionIR.com

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in Pressure BioSciences Inc. PBIO | Leave a comment

MissionIRNewsBreaks – Pacific Software, Inc. (PFSF) Inks Definitive Agreement to Commence Construction of E-Commerce Trade Platform

Emerging development technology corporation Pacific Software (OTC: PFSF) today announced that it has signed a definitive agreement with Cobalt 47 Technologies LTD, a spin-off of KBQuest Group, to commence construction of its proprietary e-commerce trade platform. Anticipated to be in production by November 2018, the multi-lingual e-commerce B2B and B2C trade platform will integrate blockchain technology solutions including Pacific Software’s Agri-Blockchain. The platform is being developed to enable trade between Brazil’s exporters and China’s importers and will integrate with international distribution channels. The company also intends to implement digital marketing campaigns on the platform to increase global revenue generation. “We are excited to begin construction of our e-commerce trade platform,” Pacific Software president Peter Pizzino stated in the news release. “The initiation of this new platform supports our mission to design, develop and commercialize Hyperledger blockchain technology solutions to establish trust with businesses trading products internationally.”

To view the full press release, visit http://ibn.fm/nT87L

About Pacific Software Inc.

Pacific Software, Inc. (OTC: PFSF) is an emerging development technology corporation positioned for investments, mergers and acquisitions of software technologies and platforms. The company is a designer, developer and commercial distributor of blockchain-based systems. The company intends to be uniquely positioned to deliver B2B and B2C blockchain solutions by utilizing IBM’s Hyperledger Blockchain “Backend as a Service” (BaaS) Infrastructure for three key industries: Agriculture, to target farm-to-table beef exports; Cannabis, to improve Seed-to-Sale supply chain management and traceability; and Opioids/Controlled Substance Management, to create a verifiable and trusted ledger between pharmaceutical manufacturers and consumers. For more information, visit the company’s website at www.PacificSoftwareInc.com.

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in MissionIRNewsBreaks, Pacific Software Inc. (PFSF) | Leave a comment

Pressure BioSciences, Inc. (PBIO) and Ohio State University Work on Groundbreaking Method to Preserve Foods and Beverages

  • Project backed by $891,000 grant from U.S. Department of Agriculture
  • Ohio State gives Pressure BioSciences $318,000 contract to design and build “first-in-kind” bench-top and floor model Ultra Shear Technology equipment
  • Game-changing technology could provide cost-effective methods of preserving milk, other dairy products and juices at room temperature and without the need for chemical preservatives

Pressure BioSciences Inc. (OTCQB: PBIO), a leading developer of innovative pressure-based solutions for the global life sciences industry, and the highly-regarded College of Food, Agricultural and Environmental Sciences (CFAES) of The Ohio State University, are collaborating to create a cost-effective and game-changing new method of allowing beverages and liquid foods to be stored at room temperature, according to a recent company press release (http://ibn.fm/Sn57d). The company believes that its Ultra Shear Technology (UST) can be scaled up to make it possible to preserve foodstuffs such as milk, other dairy products and juices without the use of additives and without compromising their look, texture or fresh taste. The company believes that UST will also allow these foods to be conveniently stored at room temperature for extended periods of time.

Combining high pressure and high shear forces while minimizing exposure to damaging high temperatures, this innovative method is expected to allow for the manufacture of healthier and better tasting products by eliminating the need for chemical preservatives and reducing thermal damage.

“The ultimate goal of this collaborative project is for consumers to benefit from the increased availability of wholesome, healthy, better-tasting, shelf-stable, clean label liquid food and beverage options. Imagine liquid foods like milk shipped and stored at room temperature for extended periods of time post-processing, while retaining superior nutritional and taste qualities,” Pressure BioSciences President and CEO Richard T. Schumacher said in a news release.

The U.S. Department of Agriculture’s National Institute of Food and Agriculture is funding the project with an $891,000 grant over four years, extended to Ohio State’s College of Food, Agricultural and Environmental Sciences. Because of its expertise in high pressure and high-pressure equipment, Ohio State sub-contracted Pressure BioSciences to create bench-top and plant floor equipment in a deal worth $318,000.

At the moment, although there are high-pressure processing (HPP) methods that extend shelf-life and reduce disease-causing microbes, these methods are expensive and non-efficient. HPP can reduce food-borne pathogens and extend shelf-life without the need for chemical additives, but it remains a batch process that’s not capable of continuous flow. Because it is only a pasteurization process that does not render food commercially sterile, HPP-processed food must be stored and shipped under refrigeration at all times. “We believe that Ultra Shear Technology will provide economical solutions to these problems, and will offer an additional, clean label processing choice to both consumers and the food industry around the world,” Pressure BioSciences’ Senior Vice President of Engineering, Dr. Edmund Y. Ting, Sr., added.

The joint Ohio State University-Pressure BioSciences program is headed by Dr. V.M. “Bala” Balasubramaniam, a professor of food engineering at CFAES who is known internationally for his research on high-pressure and other types of nonthermal processing and safe processing of food using reduced heat. “We believe UST can be used by food manufacturers for the processing of healthier and improved beverages, sauces, condiments and other foods,” he stated in a news release. Balasubramaniam works with a multidisciplinary team of chemists, microbiologists and nutritionists at Ohio State’s CFAES that investigates innovative food technologies and collaborates with industry entities to implement these technologies commercially.

The program offers the potential to bring revolutionary advantages and cost savings to the consumer and the dairy industry, but also to schools, the military, disaster relief agencies and other such groups, according to Schumacher.

He added that this promising project comes against a backdrop of positive developments for the company. “With our core business showing consistent revenue growth, our BaroFold acquisition generating revenue much sooner than planned, and our Ultra Shear Technology platform getting off to an impressive start, we believe PBIO has now positioned itself well for rapid, explosive growth in the months and years ahead.”

For more information, visit the company’s website at www.PressureBioSciences.com

About MissionIR

MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

For more information, visit www.MissionIR.com

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in Pressure BioSciences Inc. PBIO | Leave a comment

Earth Science Tech, Inc. (ETST) Thinking of the Future in the CDB Space

  • The company is working to be a major provider of premier CDB products
  • ETST’S three subsidiaries focus on developing its role as a global leader in the CBD space
  • ETST is forward-thinking – centering on the science, research and studies of its high-grade hemp CBD oil

Based in Doral, Florida, Earth Science Tech, Inc. (OTC: ETST) is a biotechnology company with three wholly owned subsidiaries. Through these, it operates in the fields of hemp cannabinoid (CBD), nutraceutical, pharmaceutical and medical device research and development. CBD offered by the company is in the form of vitamins, minerals, herbs, botanicals, personal care products, homeopathies, functional foods and other products.

CBD is a naturally occurring constituent of industrial hemp oil. ETST is advancing its efforts to be a major provider of premier CDB products. Business Insider recently noted (http://ibn.fm/z2Jqd) that “CBD is estimated to make up a roughly $1 billion industry, but the recent federal approval could make it even more lucrative by jump-starting demand for CBD-based products.”

ETST’s wholly owned subsidiaries are Earth Science Pharmaceutical Inc., Cannabis Therapeutics Inc., and KannaBidioiD, Inc. These subsidiaries center on developing ETST’s role as an international leader in the CBD space. They also focus on expanding the company’s work in the pharmaceutical and medical device sectors.

Earth Science Pharmaceutical’s mission is to develop low cost, noninvasive diagnostic tools, medical devices, testing processes and vaccines for sexually transmitted infections and/or diseases. Cannabis Therapeutics’ emphasis is on developing new, pioneering, cannabinoid-based pharmaceutical and nutraceutical products. KannaBidioiD (KBD) focuses on products for the recreational cannabis space.

Furthermore, ETST has its Canadian subsidiary, Canna Inno Laboratories, Inc. (Montreal, Québec), which it acquired last year. The company established this subsidiary to give it a position in the province and to provide it with access to government grants.

ETST’s three-year strategic plan, created in 2017, includes expansion into Canada. The company recently attended the largest Cannabis Expo in Canada, the Lift and Co. Expo.

In a news release, Dr. Michel Aubé, ETST’S chief executive officer and chief scientific officer, said, “I met many leaders in the Canadian medical cannabis industry, as well as future leaders in the burgeoning legal recreational cannabis industry and visionary lenders who are active in financing cannabis industry growth. We will pursue some of these new relationships in the coming months.”

ETST is now developing three new CBD formulas that are under a provisory patent. One CBD formula product is a neuron protector and the other is a breast protector. The third CBD formula is a new kind of superfood with distinctive organoleptic properties.

ETST is moving forward concentrating on the science, research and study of its high-grade hemp CBD oil as a nutraceutical and dietary supplement. In addition, the company has completed the set-up of its scientific advisory council with a team of recognized scientists. Furthermore, it is making its entry into the medical devices market via collaborative partnerships. ETST’s management team, with decades of experience in the nutraceutical, dietary supplement and life sciences sectors, is steering the company in an exciting direction.

For more information, visit the company’s website at www.EarthScienceTech.com

About MissionIR

MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

For more information, visit www.MissionIR.com

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in Earth Science Tech, Inc. ETST | Leave a comment

MissionIRNewsBreaks – Pressure BioSciences Inc. (PBIO) President and CEO Discusses Recent Company Activities in Interview on Uptick Newswire’s “Stock Day” Podcast

Uptick Newswire this morning released an interview on its “Stock Day” Podcast with Richard T. Schumacher, president and CEO of Pressure BioSciences (OTCQB: PBIO). PBIO is a global life sciences company with three unique, patent protected technology platforms. Among other highlights from the interview, Schumacher discussed the company’s patented technology platform called Ultra Sheer Technology (“UST”). UST is comprised of putting liquids under pressure and then releasing the liquid material while still under pressure through a series of valves. This process kills bacteria or viruses in the liquid, allowing it to sit at room temperature for extended periods of time. “We believe that UST has the potential of delivering to consumers liquid food products that actually look and taste good while having a longer shelf life without preservatives or refrigeration. Additionally, UST processing offers potential applications that go well beyond food to include pharmaceuticals and nutraceuticals and other items such as lubricants, paints, and cosmetics,” Pressure BioSciences president and CEO Richard T. Schumacher stated in the interview.

To listen to the full interview, visit http://ibn.fm/ai3ic

To view the full press release, visit http://ibn.fm/3XGw9

About Pressure BioSciences Inc.

Pressure BioSciences, Inc. (OTCQB: PBIO) is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences industry. Our products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or “PCT”) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions (e.g., cell lysis, biomolecule extraction). Our primary focus is in the development of PCT-based products for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil & plant biology, forensics, and counter-bioterror applications. Additionally, major new market opportunities have emerged in the use of our pressure-based technologies in the following areas: (1) the use of our recently acquired PreEMT technology from BaroFold, Inc. to allow entry into the biologics contract research services sector, and (2) the use of our recently-patented, scalable, high-efficiency, pressure-based Ultra Shear Technology (“UST”) platform to (i) create stable nanoemulsions of otherwise immiscible fluids (e.g., oils and water) and to (ii) prepare higher quality, homogenized, extended shelf-life or room temperature stable low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies. For more information, visit the company’s website at www.PressureBiosciences.com

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Posted in MissionIRNewsBreaks, Pressure BioSciences Inc. PBIO | Leave a comment